HIGHLIGHTS
- who: Zongqing Peng from the Department of General Surgery, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Zhongyuan Road No7, Xiangyang, Hubei Province, China have published the article: MAPKAPK5-AS1 drives the progression of hepatocellular carcinoma via regulating miR-429/ZEB1 axis, in the Journal: (JOURNAL)
- what: In this study, MAPKAPK5-AS1 expression in HCC tissues and cell lines was detected, and the interactions of MAPKAPK5-AS1, miR-429 and ZEB1 in HCC development were explored. This study reports that MAPKAPK5-AS1 expression is upregulated in HCC, and MAPKAPK5AS1 acts as . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.